Veeva Clinical and Quality Cloud Revisited
Take a fresh look at existing Veeva capabilities through the lens of today’s clinical research environment. Explore opportunities to get more value from functionality already available, informed by Just in Time GCP’s clinical, GCP quality, and inspection readiness expertise.
Clinical research continues to evolve. ICH E6(R3) has reinforced the importance of risk-proportionate approaches to quality and oversight, building on the industry’s continued adoption of Risk-Based Quality Management (RBQM). Studies are becoming increasingly complex, while trial management teams continue to balance limited resources with growing expectations for quality and inspection readiness.
As clinical research and trial management evolve, there is value in periodically looking at the technology that supports it with a fresh perspective.
Not because the technology needs to change. Because the way we use it can continue to mature.
That is the inspiration behind Veeva Clinical and Veeva Quality Cloud Revisited, a new series from Just in Time GCP exploring existing Veeva capabilities through the lens of today’s clinical research environment.
Within the series, we’ll take focused looks at specific areas of Veeva Clinical and Veeva Quality Cloud, focusing on opportunities to maximize the value of functionality already available
Explore the Content Series
